487 related articles for article (PubMed ID: 25304492)
1. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3alpha-hydroxysteroid dehydrogenase.
Penning TM
J Steroid Biochem Mol Biol; 1999; 69(1-6):211-25. PubMed ID: 10418995
[TBL] [Abstract][Full Text] [Related]
3. The rate-determining steps of aldo-keto reductases (AKRs), a study on human steroid 5β-reductase (AKR1D1).
Chen M; Jin Y; Penning TM
Chem Biol Interact; 2015 Jun; 234():360-5. PubMed ID: 25500266
[TBL] [Abstract][Full Text] [Related]
4. Aldo-keto reductases in which the conserved catalytic histidine is substituted.
Di Costanzo L; Penning TM; Christianson DW
Chem Biol Interact; 2009 Mar; 178(1-3):127-33. PubMed ID: 19028475
[TBL] [Abstract][Full Text] [Related]
5. Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.
Penning TM; Wangtrakuldee P; Auchus RJ
Endocr Rev; 2019 Apr; 40(2):447-475. PubMed ID: 30137266
[TBL] [Abstract][Full Text] [Related]
6. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
[TBL] [Abstract][Full Text] [Related]
7. Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.
Tipparaju SM; Barski OA; Srivastava S; Bhatnagar A
Biochemistry; 2008 Aug; 47(34):8840-54. PubMed ID: 18672894
[TBL] [Abstract][Full Text] [Related]
8. The aldo-keto reductase superfamily homepage.
Hyndman D; Bauman DR; Heredia VV; Penning TM
Chem Biol Interact; 2003 Feb; 143-144():621-31. PubMed ID: 12604248
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.
Hoffmann F; Maser E
Drug Metab Rev; 2007; 39(1):87-144. PubMed ID: 17364882
[TBL] [Abstract][Full Text] [Related]
10. A new nomenclature for the aldo-keto reductase superfamily.
Jez JM; Flynn TG; Penning TM
Biochem Pharmacol; 1997 Sep; 54(6):639-47. PubMed ID: 9310340
[TBL] [Abstract][Full Text] [Related]
11. Comparative anatomy of the aldo-keto reductase superfamily.
Jez JM; Bennett MJ; Schlegel BP; Lewis M; Penning TM
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):625-36. PubMed ID: 9307009
[TBL] [Abstract][Full Text] [Related]
12. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
[TBL] [Abstract][Full Text] [Related]
13. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.
Schlegel BP; Ratnam K; Penning TM
Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994
[TBL] [Abstract][Full Text] [Related]
14. Engineering steroid hormone specificity into aldo-keto reductases.
Penning TM; Ma H; Jez JM
Chem Biol Interact; 2001 Jan; 130-132(1-3):659-71. PubMed ID: 11306084
[TBL] [Abstract][Full Text] [Related]
15. Characterization of AKR1B16, a novel mouse aldo-keto reductase.
Giménez-Dejoz J; Weber S; Barski OA; Möller G; Adamski J; Parés X; Porté S; Farrés J
Chem Biol Interact; 2017 Oct; 276():182-193. PubMed ID: 28322781
[TBL] [Abstract][Full Text] [Related]
16. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of 3 alpha-hydroxysteroid dehydrogenase.
Penning TM; Bennett MJ; Smith-Hoog S; Schlegel BP; Jez JM; Lewis M
Steroids; 1997 Jan; 62(1):101-11. PubMed ID: 9029723
[TBL] [Abstract][Full Text] [Related]
18. Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
Penning TM
Chem Res Toxicol; 2014 Nov; 27(11):1901-17. PubMed ID: 25279998
[TBL] [Abstract][Full Text] [Related]
19. Human and murine steroid 5β-reductases (AKR1D1 and AKR1D4): insights into the role of the catalytic glutamic acid.
Chen M; Wangtrakuldee P; Zang T; Duan L; Gathercole LL; Tomlinson JW; Penning TM
Chem Biol Interact; 2019 May; 305():163-170. PubMed ID: 30928400
[TBL] [Abstract][Full Text] [Related]
20. Aldo-keto reductase (AKR) superfamily: genomics and annotation.
Mindnich RD; Penning TM
Hum Genomics; 2009 Jul; 3(4):362-70. PubMed ID: 19706366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
